(Q44905240)

English

Treatment of recurrent malignant glioma by repeated intracerebral injections of human recombinant interleukin-2 alone or in combination with systemic interferon-alpha. Results of a phase I clinical trial

scientific article published on January 1, 1992

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 December 2017

Treatment of recurrent malignant glioma by repeated intracerebral injections of human recombinant interleukin-2 alone or in combination with systemic interferon-alpha. Results of a phase I clinical trial (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1541981

7 October 2022

phase I clinical trial

0 references

author name string

R. E. Merchant

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1541981

7 October 2022

D. W. McVicar

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1541981

7 October 2022

L. H. Merchant

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1541981

7 October 2022

H. F. Young

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1541981

7 October 2022

language of work or name

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1541981

7 October 2022

publication date

1 January 1992

1 reference

Europe PubMed Central

7 December 2017

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

7 December 2017

12

1 reference

Europe PubMed Central

7 December 2017

1

1 reference

Europe PubMed Central

7 December 2017

75-83

1 reference

Europe PubMed Central

7 December 2017

https://scigraph.springernature.com/pub.10.1007/bf00172459

0 references

Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas. Incidence, fate, and relevance to prognosis in 228 operated cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/1541981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

rInterferon-alpha A (Ro 22-8181) therapy for patients with malignant brain tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/1541981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunobiology of primary intracranial tumours. III. Demonstration of a qualitative lymphocyte abnormality in patients with primary brain tumours

1 reference

https://pubmed.ncbi.nlm.nih.gov/1541981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunobiology of primary intracranial tumors. Part 1: studies of the cellular and humoral general immune competence of brain-tumor patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/1541981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1541981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of human leukocyte interferon on malignant brain tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1541981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1541981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphocytic infiltration in gliomas: evidence of possible host resistance.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1541981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotherapy for malignant glioma using human recombinant interleukin-2 and activated autologous lymphocytes. A review of pre-clinical and clinical investigations

1 reference

https://pubmed.ncbi.nlm.nih.gov/1541981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship of lymphocyte invasion and survival of brain tumor patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/1541981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Histopathological and blood-brain barrier changes in rats induced by an intracerebral injection of human recombinant interleukin 2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1541981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunobiology of primary intracranial tumors. Part 10: Therapeutic efficacy of interferon in the treatment of recurrent gliomas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1541981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intralesional infusion of lymphokine-activated killer (LAK) cells and recombinant interleukin-2 (rIL-2) for the treatment of patients with malignant brain tumor

1 reference

https://pubmed.ncbi.nlm.nih.gov/1541981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T cell suppressor factor from human glioblastoma cells is a 12.5-kd protein closely related to transforming growth factor-beta

1 reference

https://pubmed.ncbi.nlm.nih.gov/1541981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adoptive immunotherapy for recurrent glioblastoma multiforme using lymphokine activated killer cells and recombinant interleukin-2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1541981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Macrophages in experimental and human brain tumors. Part 2: studies of the macrophage content of human brain tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/1541981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional analysis of interleukin-2 in immune surveillance against brain tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1541981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sterile abscesses in glioma patients treated by intraparenchymal injection of lymphokine-activated killer cells and recombinant interleukin-2: case reports

1 reference

https://pubmed.ncbi.nlm.nih.gov/1541981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00172459

1 reference

Europe PubMed Central

7 December 2017

1 reference

Europe PubMed Central

7 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44905240&oldid=1749500498"